...
【24h】

Current treatment approaches for COVID-19 and the clinical value of transfusion-related technologies

机译:Covid-19的当前治疗方法和输血相关技术的临床价值

获取原文
获取原文并翻译 | 示例
           

摘要

COVID-19 is caused by SARS-CoV-2 which is a new enveloped virus that belongs to the Beta coronavirus genus. As a major health crisis, SARS-CoV-2 has infected over a million people around the world. There is currently no specific treatment available for patients with COVID-19 infection. Numerous potential therapies, including supportive intervention, immunomodulatory agents, antiviral therapy, and convalescent plasma transfusion, have been used in clinical practice. Herein, we summarize the current potential therapeutic approaches for diseases related to COVID-19 infection and discusses the clinical value of blood transfusion-related technologies used in COVID-19 treatment.
机译:2019冠状病毒疾病由SARS COV-2引起,属于一种新的包膜病毒属β-冠状病毒属。SARS-CoV-2作为一种重大的健康危机,已经在全世界感染了100多万人。2019冠状病毒疾病患者目前尚无特效治疗方法。许多潜在的治疗方法,包括支持性干预、免疫调节剂、抗病毒治疗和恢复期血浆输注,已在临床实践中使用。在此,2019冠状病毒疾病2019冠状病毒疾病的治疗方法,并讨论了输血相关技术在COVID-19治疗中的临床价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号